What Is Humalog? Everything You Should Know Before Starting

Humalog at a glance:

• Drug class: Rapid-acting prandial insulin analog
• Manufacturer: Eli Lilly
• FDA approved: 1996
• Route: subcutaneous injection (KwikPen, vial, or pump); IV in hospital
• Typical frequency: before meals (within 15 minutes of starting to eat)
• Half-life: ~1 hour (onset 15 minutes; duration 3–5 hours)
• Cash price (US): ~$275–$330/month list; authorized generic ~$130; $35 Medicare cap; Lilly Insulin Value Program caps cash at $35

Let's cut through the marketing on Humalog and look at what the data actually say. Insulin lispro has two amino-acid substitutions that prevent dimer formation, accelerating absorption from the injection site, and the result for users is: postprandial glucose control with faster onset/offset than regular human insulin.

What is Humalog?

Insulin lispro has two amino-acid substitutions that prevent dimer formation, accelerating absorption from the injection site.

Humalog is manufactured by Eli Lilly. Humalog was approved by the FDA in 1996. Its approved indications include type 1 diabetes, type 2 diabetes. Off-label use happens in clinical practice but is the prescriber's responsibility.

The drug class rapid-acting prandial insulin analog works by targeting specific receptor pathways. Let's walk through what that means in practice.

How Humalog Works in the Body

Insulin lispro has two amino-acid substitutions that prevent dimer formation, accelerating absorption from the injection site. The receptor target — compound-specific — drives the downstream effects users care about: postprandial glucose control with faster onset/offset than regular human insulin.

The pharmacokinetics matter for daily use. Humalog has a half-life of ~1 hour (onset 15 minutes; duration 3–5 hours), which determines how often it is dosed. The standard route of administration is subcutaneous injection (KwikPen, vial, or pump); IV in hospital, and the typical schedule is before meals (within 15 minutes of starting to eat).

For more detail on the underlying biology, see our breakdown of how Humalog works.

Who Uses Humalog?

Humalog is most relevant for people whose situation maps to its approved indications: type 1 diabetes; type 2 diabetes.

People who should avoid Humalog include those with the following:

• hypoglycemia

Common and Serious Side Effects

The most commonly reported side effects of Humalog include:

• hypoglycemia
• weight gain
• injection-site reactions

Serious risks — uncommon but worth knowing — include:

• severe hypoglycemia
• DKA if pump occlusion in T1D

We have a more detailed breakdown in our Humalog side-effects guide.

Humalog vs Alternatives

Other rapid-acting analogs include Novolog (aspart), Apidra (glulisine), Fiasp (faster aspart), and Lyumjev (faster lispro). If you are weighing Humalog against another option, our comparison pages include Is Humalog Safe? An Honest Look at the Side-Effect Profile, Humalog Results: What the Real Numbers Show in 2026, Why Humalog Costs So Much (and 5 Ways to Pay Less).

Bottom Line

If you're considering Humalog, the most useful next step is usually a conversation with a clinician who knows the full landscape of options — not just the one they prescribe most often. Multiple randomized controlled trials support its efficacy. If you are considering Humalog, talk to a licensed clinician first — particularly if you take other medications.

Frequently Asked Questions

Related Reading

• Is Humalog Safe? An Honest Look at the Side-Effect Profile
• Humalog Results: What the Real Numbers Show in 2026
• Why Humalog Costs So Much (and 5 Ways to Pay Less)
• Understanding Humalog Cycling: What the Research Says
• Is Lantus Right for You? An Evidence-Based Breakdown
• What Nobody Tells You About Lantus Side Effects

Sources

• Heise T et al. Insulin Pharmacokinetics and Pharmacodynamics. Diabetes Obes Metab 2017;19:3.
• American Diabetes Association. Standards of Care in Diabetes — 2024. Diabetes Care 2024;47(Suppl 1).

This page is informational only and is not medical advice. Consult a licensed clinician before starting, stopping, or changing any medication.